Results 91 to 100 of about 449,349 (233)

68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.

open access: yesNanomedicine, 2017
AIM The aim of this study was to develop a dual-modality positron emission tomography/magnetic resonance (PET/MR) imaging probe by radiolabeling gadolinium-containing AGuIX derivatives with the positron-emitter Gallium-68 (68Ga).
P. Bouziotis   +13 more
semanticscholar   +1 more source

Research Progress of PET Molecular Probes Targeting Dopamine D3 Receptor

open access: yesJournal of Isotopes, 2023
Dopamine D3 receptors are closely related to drug addiction, Parkinson’s disease (PD), schizophrenia and other neuropsychiatric diseases. PET imaging agents that target dopamine D3 receptors can noninvasively show changes in receptor density and status ...
ZHANG Ge, XUE Jingquan, ZHAO Shilun, LIU Yu, YANG Wenjiang
doaj  

A glance at imaging bladder cancer. [PDF]

open access: yes, 2018
Purpose: Early and accurate diagnosis of Bladder cancer (BCa) will contribute extensively to the management of the disease. The purpose of this review was to briefly describe the conventional imaging methods and other novel imaging modalities used for ...
Halpern, Ethan J.   +4 more
core   +1 more source

Imaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probes. [PDF]

open access: yes, 2018
Oxidative stress is a critical feature of several common neurologic disorders. The brain is well adapted to neutralize oxidative injury by maintaining a high steady-state concentration of small-molecule intracellular antioxidants including glutathione in
Carroll, Valerie N   +10 more
core   +1 more source

Status and Prospect of Radiolabeled Small Molecule Inhibitors as Tumor Imaging Agents Targeting FAP

open access: yesJournal of Isotopes
: Fibroblast activation protein (FAP) exists in tumor stromal fibroblasts and is a significant target for tumor diagnosis and treatment recently. Among the radioactive FAP-targeted tumor imaging agents, small-molecule tracers have received the most ...
HAN Peiwen1, RUAN Qing1, 2, ZHANG Junbo1
doaj   +1 more source

Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging

open access: yesNanomaterials, 2019
Early diagnosis of disease and follow-up of therapy is of vital importance for appropriate patient management since it allows rapid treatment, thereby reducing mortality and improving health and quality of life with lower expenditure for health care ...
Manuel Antonio González-Gómez   +9 more
doaj   +1 more source

Focal Spot, Spring 2009 [PDF]

open access: yes, 2009
https://digitalcommons.wustl.edu/focal_spot_archives/1111/thumbnail ...

core   +1 more source

Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments. [PDF]

open access: yes, 2012
PurposeAs imaging of the cell surface tetraspan protein epithelial membrane protein-2 (EMP2) expression in malignant tumors may provide important prognostic and predictive diagnostic information, the goal of this study is to determine if antibody ...
Braun, Jonathan   +7 more
core   +3 more sources

Positron emission tomographic imaging of Copper 64- and Gallium 68-labeled chelator conjugates of the somatostatin agonist Tyr3-octreotate [PDF]

open access: yes, 2014
The bifunctional chelator and radiometal have been shown to have a direct effect on the pharmacokinetics of somatostatin receptor (SSTR)-targeted imaging agents.
Anderson, Carolyn J   +5 more
core   +3 more sources

Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges

open access: yesInternational Journal of Nanomedicine, 2022
Anna Kastelik-Hryniewiecka,1,2 Pawel Jewula,3 Karolina Bakalorz,1 Gabriela Kramer-Marek,2,4 Nikodem Kuźnik1 1Silesian University of Technology, Faculty of Chemistry, Gliwice, Poland; 2Radiopharmacy and Preclinical PET Imaging Unit, Maria ...
Kastelik-Hryniewiecka A   +4 more
doaj  

Home - About - Disclaimer - Privacy